查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1259888

软组织肉瘤治疗市场:占有率，规模，趋势，产业分析报告，不同治疗，各适应症，各流通管道，各最终用途预测，2023年～2032年

Soft Tissue Sarcoma Treatment Market Share, Size, Trends, Analysis, Industry Report By Treatment, By Disease, By Distribution Channel, By End User and Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

全球软组织肉瘤治疗的市场规模到2032年前将达到37亿427万美元。

本报告提供全球软组织肉瘤治疗市场相关调查，提供不同治疗，各适应症，各流通管道，各最终用途，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球软组织肉瘤治疗市场洞察

  • 软组织肉瘤治疗- 产业的概述
  • 软组织肉瘤治疗市场动态
  • 波特的五力分析
  • 大环境分析
  • 软组织肉瘤治疗产业趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球软组织肉瘤治疗市场，不同治疗

  • 主要调查结果
  • 简介
    • 全球软组织肉瘤治疗市场，不同治疗，2019年～2032年(100万美元)
  • 化疗
  • 标靶治疗
  • 抗血管新生药
  • 放射治疗

第6章 全球软组织肉瘤治疗市场，各适应症

  • 主要调查结果
  • 简介
    • 全球软组织肉瘤治疗市场，各适应症，2019年～2032年(100万美元)
  • 局部
  • 局部
  • 转移性肉瘤

第7章 全球软组织肉瘤治疗市场，各最终用途

  • 主要调查结果
  • 简介
    • 全球软组织肉瘤治疗市场，各最终用途，2019年～2032年(100万美元)
  • 医院
  • 居家护理
  • 其他

第8章 全球软组织肉瘤治疗市场，各流通管道

  • 主要调查结果
  • 简介
    • 全球软组织肉瘤治疗市场，各流通管道，2019年～2032年(100万美元)
  • 线上药局
  • 零售药局
  • 其他

第9章 全球软组织肉瘤治疗市场，各地区

  • 主要调查结果
  • 简介
    • 软组织肉瘤治疗市场评估，各地区，2019年～2032年(100万美元)
  • 软组织肉瘤治疗市场-北美
  • 软组织肉瘤治疗市场-欧洲
  • 软组织肉瘤治疗市场-亚太地区
  • 软组织肉瘤治疗市场-中东·非洲
  • 软组织肉瘤治疗市场-南美

第10章 竞争情形

第11章 企业简介

  • Bristol-Myers Squibb
  • Merck & Co.
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer Inc
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Amgen Inc
  • Celgene Corporation
  • Johnson & Johnson
Product Code: PM1620

The global soft tissue sarcoma treatment market size is expected to reach USD 3,704.27 million by 2032, according to a new study by Polaris Market Research. The report "Soft Tissue Sarcoma Treatment Market Share, Size, Trends, Analysis, Industry Report By Treatment, By Disease, By Distribution Channel, By End Use and Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Soft tissue sarcoma is a rare type of cancer that forms in the soft tissues of the body, such as muscles, tendons, fat, and nerves. Although it can occur in any part of the body, it is most commonly found in the arms, legs, chest, and abdomen. Soft tissue sarcoma can be difficult to diagnose, but early detection and treatment can improve the chances of a successful outcome.

Treatment for soft tissue sarcoma depends on several factors, including the size, location, and stage of the tumor, as well as the patient's overall health. Surgery is often the first line of treatment, and it may involve removing the tumor and some surrounding tissue. In some cases, radiation therapy may be used to shrink the tumor before surgery or to kill any remaining cancer cells after surgery. Chemotherapy is not typically used to treat soft tissue sarcoma, but it may be used in certain cases.

The tumor has spread to other parts of the body, chemotherapy may be used to slow the growth of the cancer and relieve symptoms. Additionally, some patients may be candidates for targeted therapy, which uses drugs to target specific proteins or genes that are involved in the growth and spread of cancer cells.

In addition to medical treatment, patients with soft tissue sarcoma may benefit from supportive care, such as physical therapy, occupational therapy, and counseling. These services can help patients manage symptoms, cope with the emotional impact of cancer, and improve their overall quality of life. The prognosis for soft tissue sarcoma varies depending on several factors, including the stage of the cancer, the location of the tumor, and the patient's overall health.

Soft Tissue Sarcoma Treatment Market Report Highlights:

Anti-Angiogenesis segment is driven by the rising prevalence of cancer and the need for effective treatments. Anti-angiogenesis drugs use a molecular approach to inhibit the growth of new blood vessels which tumors need to spread.

The demand for effective treatments is high. The Metastatic Sarcoma segment is expected to be driven by the development of new drugs, such as immunotherapies and targeted therapies, which have proven to be effective in treating this type of cancer.

Increasing prevalence of this type of cancer in the region, as well as the availability of advanced treatments. Additionally, the increasing focus on research and development of innovative treatments, such as immunotherapies and targeted therapies, is expected to drive the demand for soft tissue sarcomas in North America.

The global players include Bristol-Myers Squibb, Merck & Co., Eli Lilly and Company, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, AstraZeneca plc, Amgen Inc., Celgene Corporation, Johnson & Johnson, Bayer AG, AbbVie Inc., Sanofi, Takeda Pharmaceuticals, and Gilead Sciences.

Polaris Market Research has segmented the Soft Tissue Sarcoma Treatment market report based on component, Treatment, Indication, Distribution Channel, end-use, and region:

Soft Tissue Sarcoma Treatment, Treatment Outlook (Revenue, USD Million, 2019-2032)

Chemotherapy

Targeted Therapy

Anti-angiogenesis drugs

Radiation Therapy

Soft Tissue Sarcoma Treatment, Indication Outlook (Revenue, USD Million, 2019-2032)

Regional

Local

Metastatic Sarcoma

Soft Tissue Sarcoma Treatment, Distribution Channel Outlook (Revenue, USD Million, 2019-2032)

Online Pharmacy

Retail Pharmacy

Other

Soft Tissue Sarcoma Treatment, End User Outlook (Revenue, USD Million, 2019-2032)

Hospitals

Homecare

Others

Soft Tissue Sarcoma Treatment, Regional Outlook (Revenue - USD Million, 2019-2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Soft Tissue Sarcoma Treatment Market Insights

  • 4.1. Soft Tissue Sarcoma Treatment - Industry Snapshot
  • 4.2. Soft Tissue Sarcoma Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Involvement of Clinical Trials
      • 4.2.1.2. Increase in Cancer Cases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Increasing Cost Of Treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Soft Tissue Sarcoma Treatment Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Soft Tissue Sarcoma Treatment Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • 5.3. Chemotherapy
    • 5.3.1. Global Soft Tissue Sarcoma Treatment Market, by Chemotherapy, by Region, 2019-2032 (USD Million)
  • 5.4. Targeted Therapy
    • 5.4.1. Global Soft Tissue Sarcoma Treatment Market, by Targeted Therapy, by Region, 2019-2032 (USD Million)
  • 5.5. Anti-angiogenesis drugs
    • 5.5.1. Global Soft Tissue Sarcoma Treatment Market, by Anti-angiogenesis drugs, by Region, 2019-2032 (USD Million)
  • 5.6. Radiation Therapy
    • 5.6.1. Global Soft Tissue Sarcoma Treatment Market, by Radiation Therapy, by Region, 2019-2032 (USD Million)

6. Global Soft Tissue Sarcoma Treatment Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • 6.3. Regional
    • 6.3.1. Global Soft Tissue Sarcoma Treatment Market, by Regional, by Region, 2019-2032 (USD Million)
  • 6.4. Local
    • 6.4.1. Global Soft Tissue Sarcoma Treatment Market, by Local, by Region, 2019-2032 (USD Million)
  • 6.5. Metastatic Sarcoma
    • 6.5.1. Global Soft Tissue Sarcoma Treatment Market, by Metastatic Sarcoma, by Region, 2019-2032 (USD Million)

7. Global Soft Tissue Sarcoma Treatment Market, by End-use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Soft Tissue Sarcoma Treatment Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 7.4. Homecare
    • 7.4.1. Global Soft Tissue Sarcoma Treatment Market, by Homecare, by Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Soft Tissue Sarcoma Treatment Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.3. Online Pharmacy
    • 8.3.1. Global Soft Tissue Sarcoma Treatment Market, by Online Pharmacy, by Region, 2019-2032 (USD Million)
  • 8.4. Retail Pharmacy
    • 8.4.1. Global Soft Tissue Sarcoma Treatment Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 8.5. Other
    • 8.5.1. Global Soft Tissue Sarcoma Treatment Market, by Other, by Region, 2019-2032 (USD Million)

9. Global Soft Tissue Sarcoma Treatment Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Soft Tissue Sarcoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Soft Tissue Sarcoma Treatment Market - North America
    • 9.3.1. North America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 9.3.2. North America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.3.3. North America: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
    • 9.3.4. North America: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.3.5. Soft Tissue Sarcoma Treatment Market - U.S.
      • 9.3.5.1. U.S.: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.3.6. Soft Tissue Sarcoma Treatment Market - Canada
      • 9.3.6.1. Canada: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • 9.4. Soft Tissue Sarcoma Treatment Market - Europe
    • 9.4.1. Europe: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 9.4.2. Europe: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.4.3. Europe: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
    • 9.4.4. Europe: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.5. Soft Tissue Sarcoma Treatment Market - UK
      • 9.4.5.1. UK: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.6. Soft Tissue Sarcoma Treatment Market - France
      • 9.4.6.1. France: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.6.2. France: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.6.3. France: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.6.4. France: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.7. Soft Tissue Sarcoma Treatment Market - Germany
      • 9.4.7.1. Germany: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.8. Soft Tissue Sarcoma Treatment Market - Italy
      • 9.4.8.1. Italy: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.9. Soft Tissue Sarcoma Treatment Market - Spain
      • 9.4.9.1. Spain: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.10. Soft Tissue Sarcoma Treatment Market - Netherlands
      • 9.4.10.1. Netherlands: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.4.11. Soft Tissue Sarcoma Treatment Market - Russia
      • 9.4.11.1. Russia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • 9.5. Soft Tissue Sarcoma Treatment Market - Asia Pacific
    • 9.5.1. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.5.5. Soft Tissue Sarcoma Treatment Market - China
      • 9.5.5.1. China: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.5.3. China: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.5.5.4. China: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.5.6. Soft Tissue Sarcoma Treatment Market - India
      • 9.5.6.1. India: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.6.3. India: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.5.6.4. India: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.5.7. Soft Tissue Sarcoma Treatment Market - Japan
      • 9.5.7.1. Japan: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.5.8. Soft Tissue Sarcoma Treatment Market - Malaysia
      • 9.5.8.1. Malaysia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.5.9. Soft Tissue Sarcoma Treatment Market - Indonesia
      • 9.5.9.1. Indonesia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.5.10. Soft Tissue Sarcoma Treatment Market - South Korea
      • 9.5.10.1. South Korea: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • 9.6. Soft Tissue Sarcoma Treatment Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.6.5. Soft Tissue Sarcoma Treatment Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.6.6. Soft Tissue Sarcoma Treatment Market - South Africa
      • 9.6.6.1. South Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.6.7. Soft Tissue Sarcoma Treatment Market - Israel
      • 9.6.7.1. Israel: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.6.8. Soft Tissue Sarcoma Treatment Market - UAE
      • 9.6.8.1. UAE: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • 9.7. Soft Tissue Sarcoma Treatment Market - Latin America
    • 9.7.1. Latin America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.7.5. Soft Tissue Sarcoma Treatment Market - Mexico
      • 9.7.5.1. Mexico: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.7.6. Soft Tissue Sarcoma Treatment Market - Brazil
      • 9.7.6.1. Brazil: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
    • 9.7.7. Soft Tissue Sarcoma Treatment Market - Argentina
      • 9.7.7.1. Argentina: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Bristol-Myers Squibb
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Merck & Co.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Eli Lilly and Company
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Novartis AG
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Pfizer Inc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GlaxoSmithKline plc
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. AstraZeneca plc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Amgen Inc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Celgene Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Johnson & Johnson
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables

  • Table 1 Global Soft Tissue Sarcoma Treatment Market, by Treatment, by Region, 2019-2032 (USD Million)
  • Table 2 Global Soft Tissue Sarcoma Treatment Market, by Indication, by Region, 2019-2032 (USD Million)
  • Table 3 Global Soft Tissue Sarcoma Treatment Market, by End-use, by Region, 2019-2032 (USD Million)
  • Table 4 Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
  • Table 5 Soft Tissue Sarcoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 North America: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 8 North America: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 9 North America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 10 U.S.: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 U.S.: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 12 U.S.: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 13 U.S.: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Canada: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 15 Canada: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 16 Canada: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 17 Canada: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 18 Europe: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 Europe: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 20 Europe: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 21 Europe: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 22 Germany: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Germany: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 25 Germany: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 France: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 27 France: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 28 France: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 29 France: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 30 UK: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 UK: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 32 UK: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 33 UK: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 34 Italy: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Italy: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 36 Italy: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 37 Italy: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Netherlands: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 39 Netherlands: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 40 Netherlands: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 41 Netherlands: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 42 Spain: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 Spain: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 44 Spain: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 45 Spain: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 46 Russia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Russia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 48 Russia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 49 Russia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 54 China: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 China: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 56 China: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 57 China: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 58 Japan: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Japan: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 60 Japan: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 61 Japan: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 India: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 63 India: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 64 India: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 65 India: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 66 Indonesia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 Indonesia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 68 Indonesia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 69 Indonesia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 70 Malaysia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 71 Malaysia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 72 Malaysia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 73 Malaysia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 South Korea: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 75 South Korea: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 76 South Korea: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 77 South Korea: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 78 Latin America: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 79 Latin America: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 80 Latin America: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 81 Latin America: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 82 Brazil: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 83 Brazil: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 84 Brazil: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 85 Brazil: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 86 Mexico: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 87 Mexico: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 88 Mexico: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 89 Mexico: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 90 Argentina: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 91 Argentina: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 92 Argentina: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 93 Argentina: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 98 UAE: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 99 UAE: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 100 UAE: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 101 UAE: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 106 South Africa: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 107 South Africa: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 108 South Africa: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 109 South Africa: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 110 Israel: Soft Tissue Sarcoma Treatment Market, by Treatment, 2019-2032 (USD Million)
  • Table 111 Israel: Soft Tissue Sarcoma Treatment Market, by Indication, 2019-2032 (USD Million)
  • Table 112 Israel: Soft Tissue Sarcoma Treatment Market, by End-use, 2019-2032 (USD Million)
  • Table 113 Israel: Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Soft Tissue Sarcoma Treatment Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment
  • Figure 7. Global Soft Tissue Sarcoma Treatment Market, by Treatment, 2021 & 2030 (USD Million)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Soft Tissue Sarcoma Treatment Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 10. Market by Indication
  • Figure 11. Global Soft Tissue Sarcoma Treatment Market, by Indication, 2021 & 2030 (USD Million)
  • Figure 12. Market by End-use
  • Figure 13. Global Soft Tissue Sarcoma Treatment Market, by End-use, 2021 & 2030 (USD Million)